Gene expression levels of cytokine profile and cytotoxic markers in non-immediate reactions to drugs

Blood cells, molecules and diseases

Volumn 29, Issue 2, 2002, Pages 179-189

  Posadas, Sinforiano J ^a   Torres, María J ^b   Mayorga, Cristobalina ^b   Juarez, Carlos ^b   Blanca, Miguel ^a  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^b HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

Author keywords

Allergy; FasL; Granzyme B; Perforin; Th1 Th2

Indexed keywords

BIOLOGICAL MARKER; CYTOKINE; MESSENGER RNA;

ADULT; ARTICLE; CASE CONTROL STUDY; CYTOTOXIC T LYMPHOCYTE; DELAYED HYPERSENSITIVITY; DRUG HYPERSENSITIVITY; FEMALE; GENETICS; HUMAN; IMMUNOLOGY; MALE; MIDDLE AGED; MONONUCLEAR CELL; PATHOLOGY; RASH; STEVENS JOHNSON SYNDROME; TH1 CELL; TIME; TOXIC EPIDERMAL NECROLYSIS;

ADULT; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CYTOKINES; DRUG HYPERSENSITIVITY; EPIDERMAL NECROLYSIS, TOXIC; EXANTHEMA; FEMALE; HUMANS; HYPERSENSITIVITY, DELAYED; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; RNA, MESSENGER; STEVENS-JOHNSON SYNDROME; T-LYMPHOCYTES, CYTOTOXIC; TH1 CELLS; TIME FACTORS;

EID: 2342639145     PISSN: 10799796     EISSN: None     Source Type: Journal    
DOI: 10.1006/bcmd.2002.0555     Document Type: Article

References (46)

1. R. Hoigné F. Stocker P. Middelton Epidemiology of drug allergy A.L. de Weck H. Bundgaard Allergic Reactions to Drugs. Handbook of Experimental Pharmacology 1983 Springer-Verlag Berlin 187 205
2. N.H. Shear Diagnosing cutaneous adverse reactions to drugs Arch. Dermatol. 126 1990 94 97
3. B.B. Levine Immunologic mechanisms of penicillin allergy. A haptenic model system for the study of allergic diseases of man N. Engl. J. Med. 275 1966 1115 1125
4. M.J. Torres C. Mayorga R. Pamies C. Juarez A. Romano M. Blanca Immunological response to different determinants of benzylpenicillin, amoxicillin and ampicillin. Comparison between urticaria and anaphylactic shock Allergy 54 1999 936 943
5. J.C. Rojeau R.S. Stern Severe cutaneous adverse reactions to drugs N. Engl. J. Med. 331 1994 1272 1285
6. N. Yawalkar W.J. Pichler Pathogenesis of drug-induced exanthema Int. Arch. Allergy Immunol. 124 2001 336 338
7. M. Blanca C. Mayorga M.J. Torres R. Warrington A. Romano P. Demoly F. Silviu-Dan M. Moya J. Fernandez C. Juarez Side-chain-specific reactions to betalactams: 14 years later Clin Exp Al. 32 2002 192 197
8. H.U. Weltzien E. Padovan Molecular features of penicillin allergy J. Invest. Dermatol. 110 1998 203 206
9. C. Brander D. Mauri-Helweg H.P. Rolli M. Goldman W.J. Pichler Heterogeneous T cell response to betalactam modified self structures in penicillin allergic individuals J. Immunol. 155 1995 2670 2678
10. D. Mauri-Helweg F. Bettens D. Mauri C. Brander T. Hunziker W.J. Pichler Activation of drug-specific CD4+ and CD8+ T cells in individuals allergic to sulfonamides, phenytoin and carbamazepine J. Immunol. 155 1995 462 472
11. K. Katagiri S. Itami Y. Hatano S. Takayasu Increased levels of IL-13 mRNA, but not IL-4, are found in vivo in peripheral blood mononuclear cells (PBMC) of patients with atopic dermatitis (AD) Clin. Exp. Immunol. 108 1997 289 294
12. L. Leyva M.J. Torres S. Posadas M. Blanca F. O′Valle Anticonvulsant induced toxic epidermal necrolysis. Monitorization of the immunologic response J. Allergy Clin. Immunol. 105 2000 157 165
13. S.J. Posadas L. Leyva M.J Torres J.L. Rodriguez I. Bravo M. Rosal J. Fernandez C. Juarez M. Blanca Subjects with allergic reactions to drugs show in vivo polarized patterns of cytokine expression depending on the chronology of the clinical reaction J. Allergy Clin. Immunol. 106 2000 769 776
14. M. Blanca S. Posadas M.J. Torres L. Leyva C. Mayorga L. González C. Juarez J. Fernandez L. Santamarı́a Expression of the skin-homing receptor in peripheral blood lymphocytes from subjects with non-immediate cutaneous allergic drug reactions Allergy 55 2000 998 1004
15. G. Berke The CTL′s kiss of death Cell 81 1995 9 12
16. N. Yawalkar R.E. Hunger C. Buri S. Schmid F. Egli C.U. Brand C. Mueller W.J. Pichler L.R. Braathen A comparative study of the expression of cytotoxic proteins in allergic contact dermatitis and psoriasis Am. J. Pathol. 158 2001 803 808
17. N. Yawalkar S. Schmid L.R. Braathen W.J. Pichler Perforin and granzyme B may contribute to skin inflammation in atopic dermatitis and psoriasis Br. J. Dermatol. 144 2001 1133 1139
18. B. Baima M. Sticherling Apoptosis in different cutaneous manifestations of lupus eruthematosus Br. J. Dermatol. 144 2001 958 966
19. N. Yawalkar F. Egli Y. Hari H. Nievergelt L.R. Braathen Infiltration of cytotoxic T cells in drug-induced cutaneous eruptions Clin. Exp. Allergy 30 2000 847 855
20. S. Posadas A. Padial M.J. Torres L. Leyva E. Sanchez-Sabaté J. Alvarez M. Blanca Delayed reactions to drugs show levels of perforin, granzyme B and Fas-L related to disease severity J. Allergy Clin. Immunol. 109 2002 155 161
21. S. Terrados M. Blanca J. Garcı́a J.M. Vega M.J. Torres Non-immmediate reactions to beta-lactams, prevalence and the role of different pennicillins Allergy 50 1995 563 567
22. D.S. Wilkinson S. Fregert B. Magnuson H.J. Bandmann C.D. Calnan E. Cronin Terminology of contact dermatitis Acta Derm. Venereol. 50 1970 287 292
23. A.A. Fisher Contact Dermatitis 1988 Lea & Febiger Philadelphia p. 954
24. P. Chomczysnky N. Sacchi Single step method of RNA isolation by acid guanidinium thiocyanate–phenol–chloroform extraction Anal. Biochem. 162 1987 156 159
25. J.C. Szepietowski R.C. Mckenzie S.G. Keohane R.D. Aldridge J.A.A. Hunter Atopic and non-atopic individuals react to nickel challenge in a similar way. A study of the cytokine profile in nickel-induced contact dermatitis Br. J. Dermatol. 137 1997 195 200
26. Y. Sugita M. Miyamoto M. Koseki N. Ishii H. Nakajima Suppression of tumour necrosis factor-(alpha) expression in leprosy skin lesions during treatment for leprosy Br. J. Dermatol. 136 1997 393 397
27. S. Ikura K. Terao I. Matsuzaki M. Inoue-Murayama Y. Murayama U5 monoclonal antibody identifies a novel lymphocyte surface antigen preferentially expressed in human circulating natural killer cells with high cytotoxic activity Immunology 96 1999 485 490
28. P.D. Siebert J. Larrick Competitive PCR Nature 359 1992 557 558
29. R.S. Gruchalla Drug metabolism, danger signals, and drug-induced hypersensitivity J. Allergy Clin. Immunol. 108 2001 475 488
30. M. Hertl H.F. Merck Lymphocyte activation in cutaneous drug reactions J. Invest. Dermatol. 105 1995 95S 98S
31. B. Schnyder D. Mauri-Hellweg M. Zanni F. Bettens W. Pichler Direct MHC-dependent presentation of the drug sulfamethoxazole to human alpha/beta T cell clones J. Clin. Invest. 100 1997 136 141
32. E. Padovan D. Mauri-Helweg W.J. Pichler H.U. Weltzien T cell recognition of penicillin G: Structural features determining antigenic specificity Eur. J. Immunol. 26 1996 42 48
33. M. Hertl H. Bohlen F. Jugert C. Boecker R. Knaup H. Merck Predominance of epidermal CD8+ T lymphocytes in bullous cutaneous reactions caused by β-lactam antibiotics J. Invest. Dermatol. 101 1993 794 799
34. M. Hertl J. Geisel C. Boecker H. Merk Selective generation of CD8+ T cell clones from the peripheral blood of patients with cutaneous reactions to beta-lactams antibiotics Br. J. Dermatol. 128 1993 619 626
35. I. Gaspard M-T. Guinnepain J. Laurent N. Bachot S. Kerdine J. Bertoglio IL-4 and IFN-gamma mRNA induction in human peripheral lymphocytes specific for beta-lactams antibiotics in immediate or delayed hypersensitivity reactions J. Clin. Immunol. 20 2000 107 116
36. F. Brugnolo F. Annunziato S. Sampognaro P. Campi M. Manfredi A. Matucci M. Blanca Highly Th2-skewed cytokine profile of beta-lactam specific T cells from non-atopic subjects with adverse drug reactions J. Immunol. 163 1999 1053 1059
37. C. Behrendt H. Gollnick B. Bonnekoh Up-regulated perforin expression of CD8+ blood lymphocytes in generalized non-anaphylactic drug eruptions and exacerbated psoriasis Eur. J. Dermatol. 10 2000 365 369
38. N. Rzany O. Hering M. Mockenhaupt Histopathological and epidemiological characteristics of patients with erythema exudativum multiforme major, Stevens-Johnson syndrome and toxic epiderma necrolysis Br. J. Dermatol. 135 1996 6 11
39. P.R. Walker P. Saas P.Y. Dietrich Role of Fas Ligand (CD95L) in immune scape: The tumor cell strikes back J. Immunol. 158 1997 4521
40. I. Viard P. Wehrli R. Bullani P. Shnaider N. Holler D. Salomon T. Hunziker J. Saurat T. Tschopp L.E. French Inhibition of Toxic Epidermal Necrolysis by blockade of CD95 with human intravenous immunoglobulin Science 282 1998 490 493
41. P. Paquet E. Jacob P. Damas G.E. Piérard Treatment of drug induced toxic epidermal necrolysis (Lyell′s syndrome) with intravenous human immunoglobulins Burns 27 2001 652 655
42. R. Arnold M. Seifert K. Asadullah H.D. Volk Crosstalk between keratinocytes and T lymphocytes via Fas/Fas Ligand interaction: Modulation by cytokines J. Immunol. 162 1999 7140 7147
43. R.W. Groves M.H. Allen J.N.W.N. Barker Tumor necrosis alpha is pro-inflammmatory in normal skin and modulates cutaneous adhesion molecule expression Br. J. Dermatol. 132 1995 345 352
44. A.G. Santis M.R. Campanero J. Alonso Tumor necrosis factor-(alpha) production induced in T lymphocytes the AIM/CD69 activation pathway Eur. J. Immunol. 22 1992 1253 1259
45. P. Paquet A. Nikkels J. Arrese Macrophages and tumor necrosis factor alpha in toxic epidermal necrolysis Arch. Dermatol. 130 1994 605 608
46. K.T. Teague D. Hildeman R.M. Keld T. Mitchell W. Rees B.C. Schaefer J. Bender J. Kappler P. Marrack Activation changes the spectrum but not the diversity of genes expressed by T cells Proc. Natl. Acad. Sci. USA. 96 1999 12691 12696